Digestive System TRIZ Cases

A chewable tablet combines directly compressible and non-directly compressible sugar alcohol particles to induce saliva generation upon mastication.

Mesenchymal lineage precursor cells reduce gastrointestinal bleeding in left ventricular assist device patients.

A multivitamin composition stimulates gastrointestinal motility using B vitamins and vitamin C.

Magnesium oxide granules with controlled surface area enhance tablet strength, reducing capping defects in pharmaceutical applications.

SMEDDS formulation resolves poor lipid solubility of cyclosporine analogs, achieving high oral bioavailability and prolonged liver exposure.

Monoclonal antibodies target distinct progastrin epitopes to distinguish the precursor from processed gastrin forms, resolving cross-reactivity in immunoassays.

A gene expression panel predicts subject responsiveness to multi-kinase inhibitors for personalized treatment planning.

Merges nitroglycerin with rifaximin to accelerate healing while preventing sensitization from single-agent therapies.

Multikinase inhibitors block VEGF and PDGF pathways to treat uterine fibroids and primary sclerosing cholangitis.

MBDD compounds from Antrodia cinnamomea inhibit hepatic stellate cell activity to prevent liver fibrosis.

Dissolving enteric coating signals small bowel entry, switching low power monitoring to active capture and extending battery life.

Oligopeptide inserts in mutated AAV capsid proteins improve transduction efficiency and specificity for hepatocytes, reducing high vector doses.

Developing crystalline forms A, B, and C of 1-(4-benzyloxy-benzyl)-3-methyl-thiourea enhances physical stability and purity.

Interleukin 17C measurement detects microinflammation early, preventing progression to inflammatory bowel disease.

Administering anti-KIR and anti-PD-1 antibodies together overcomes tumor immune evasion mechanisms that limit single-agent efficacy in solid tumors.

Applying 50-80 MPa pressure during fermentation eliminates salt addition while maintaining hepatic function improvement and hypertension amelioration effects.

A canine diet product containing 15 to 25 percent Ascophyllum nodosum fiber and hydrolyzed proteins facilitates intestinal rebalancing.

Isolated monoclonal antibodies bind specifically to human plasminogen activator inhibitor type-1.

A pixel circuit arranges transistors and capacitors diagonally to optimize space usage within the display panel.

Chimeric and humanized antibodies bind specifically to FGFR2 isoforms, resolving limited in vivo anti-tumor activity by blocking receptor-ligand interactions.

A unified composition of vitamin E and PUFAs mitigates coagulation disturbances while inhibiting pro-inflammatory cytokine production.

Salt formation resolves the contradiction between anti-tumor efficacy and gastric solubility, maintaining bioavailability.

Specific microbial compositions modulate the gut microbiome to enhance metabolic health indicators and glucose homeostasis.

Rapamycin conditions CD3+ T-cells to generate persistent effector cells, reducing cytokine release syndrome risk.

NLRP3 antagonists block alternative inflammatory pathways to overcome anti-TNFα resistance and improve treatment efficacy.

The synthesis removes unstable Formula II intermediates via extraction, preventing isomeric impurities and genetic toxicity while achieving high yield and purity.

Single-component poly(beta-amino ester) polymer carrier loads and protects mRNA through electrostatic interactions.

Segmenting stable carboxymethyl cellulose with enzymatic response units prevents early leakage while ensuring targeted release.

Extracellular matrix protein coatings enable rapid monoclonal stem cell proliferation without complex banking procedures.

Modified oligonucleotides decrease NLRP3 RNA and protein levels, resolving persistent inflammation in kidney disease and cardiac disorders.

A combination of branched chain fatty acid glycerides and hill shaddock oil regulates inflammatory reactions in intestinal epithelial cells.

A pharmaceutical formulation uses an alkaline core and seal coating to stabilize acid-labile benzimidazole derivatives.

Tumor-infiltrating lymphocytes expand rapidly using toll-like receptor agonists and hydrocarbon-stapled peptoid hybrids in culture media.

A sulforaphane-melatonin conjugate composition neutralizes free radicals to protect epithelial tissue.

A composition of five isolated Bifidobacterium longum strains increases microbiota diversity in the infant gut.

Reverse-phase chromatography isolates terpene monomers and oligomers from Chios mastic gum with high purity.

Anti-IL-23p19 antibodies target bowel urgency in ulcerative colitis patients through specific biomarker analysis and targeted intervention strategies.

Converting amorphous linaclotide to an alpha-crystalline phase reduces chemical degradation and improves storage stability.

MAPK kinase inhibitors block HBV recurrence by targeting signaling pathways, overcoming drug resistance from conventional nucleotide analogs.

Single-chain diabody bispecific antibodies bind TRAIL-R2 and CD3 to activate T-cell cytotoxicity while minimizing off-target toxicity.

Stable liquid anti-TNFα formulations enable subcutaneous self-injection, eliminating hospital visits and reducing treatment time from hours to minutes.

HH-F3 fraction from Graptopetalum paraguayense down-regulates AURKA expression to inhibit viability and induce apoptosis in HepG2 and Huh7 cancer cell lines.

An antibody specifically recognizes IL-11 to block receptor binding.

A qRT-PCR method detects miRNA-320a expression in stool samples to identify acute or relapsing phases of inflammatory bowel disease.

A liquid antibody formulation uses polysorbate 80 to prevent protein aggregation and maintain therapeutic integrity.

A CSF biomarker score predicts Alzheimer's progression by combining inflammatory markers to overcome amyloid stability limits.

Plant sterols serve as starting materials for synthesizing obeticholic acid analogues via novel oxidation reactions.